NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
Also ASCO to release abstracts to members prior to annual meeting.
Advisors suggest NCI establish sarcoma research consortium.
Lung cancer screening trial reaches accrual goal of 50,000.
Markison leaving Bristol-Myers, two others promoted in reorganization.
Wilding named director, Univ. of Wisconsin Cancer Center.
NABCO to close June 30.
This month’s 8-page Business & Regulatory Report included in this issue.
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









